SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-19-022638
Filing Date
2019-12-16
Accepted
2019-12-16 17:12:46
Documents
1
Period of Report
2019-12-06

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 9583
  Complete submission text file 0001140361-19-022638.txt   11962
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21429 | Film No.: 191288024
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Sharp & Dohme Corp. (Reporting) CIK: 0000942443 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21429 | Film No.: 191288025

Mailing Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803
Business Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803 781-994-0300
ARQULE INC (Issuer) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences